Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
7.52%Interest Expense Margin
VS
Market
Sector
Industry
History
$ 2.12Close
$ 1.86 - $ 7.1 52-Week Range
Ticker Information
Ticker
INMCompany Name
INMED PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQINMED PHARMACEUTICALS INC - Interest Expense Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
INM - Int. Exp. % Historical data
| Date | Interest Expense | Interest Expense Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 371.55K | 7.52% | $ 4.94M |
| 3/31/2025 | $ 351.55K | 7.14% | $ 4.92M |
| 12/31/2024 | $ 351.55K | 7.28% | $ 4.83M |
| 9/30/2024 | $ 0 | 0% | $ 4.96M |
| 6/30/2024 | $ 0 | 0% | $ 4.6M |
| 3/31/2024 | $ 0 | 0% | $ 5.63M |
| 12/31/2023 | $ 0 | 0% | $ 5.49M |
| 9/30/2023 | $ 0 | 0% | $ 4.72M |
| 6/30/2023 | $ 0 | 0% | $ 4.14M |
| 3/31/2023 | $ 0 | 0% | $ 2.34M |
Key Performance Insights, Last 5 Years
- INMED PHARMACEUTICALS INC's latest trailing twelve months (TTM) Int. Exp. % stands at 0%.
- Over the past 5 years, INMED PHARMACEUTICALS INC's average Int. Exp. % has been 1.46%.
- The median Int. Exp. % for INMED PHARMACEUTICALS INC during this period was 0%
- INMED PHARMACEUTICALS INC reached its highest Int. Exp. % over the past 5 years at 7.52%.
- The lowest Int. Exp. % recorded by INMED PHARMACEUTICALS INC in the same timeframe 0%
INMED PHARMACEUTICALS INC's Int. Exp. % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Int. Exp. % Benchmarks
Similar metrics to Revenues:
- Interest Expense - [Income Statement] Interest expense is the cost incurred by a business for borrowing funds.
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
Definition of Interest Expense Margin
[Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].Int. Exp. / Revenues
(=) Int. Exp. % Int. Exp. % for INMED PHARMACEUTICALS INC is calculated as follows: Int. Exp. [ $ 360.35K ] / Revenues [ $ 0 ]
(=) Int. Exp. % [ 0% ] INM - Interest Expense Margin, Last 5 years
0%
Minimum
Dec 31, 2021
7.52%
Maximum
Jun 30, 2025
1.46%
Average
0%
Median
Int. Exp. % Benchmark AnalysisMarket
The chart above depicts the distribution of Int. Exp. % for companies in the Total Stock Market. The average Int. Exp. % of the companies is 1.62% with a standard deviation of 2.19%.
The following table provides additional summary stats:
Int. Exp. % in the Market:
| filtered constituents | 3.15K |
|---|---|
| min | -4.94% |
| max | 8.48% |
| average | 1.62% |
| median | 0.79% |
| std | 2.19% |